文献速递前列腺癌

大型整合医疗系统中前列腺癌筛查实践:2007-2014年

Prostate cancer screening practices in a large, integrated health system: 2007-2014.
PubMed 文献 · BJU Int · 2017-02-26

研究评估2007至2014年大型整合医疗系统中160 211名≥40岁男性的前列腺癌筛查实践。年度PSA筛查率在所有年龄组均下降,非裔美国男性总体筛查率低于非非裔美国男性,初级保健提供者间PSA检测差异未见实质改变。作者认为未来工作应探索筛查实践差异来源及在初级保健中实施基于风险的前列腺癌筛查策略。

要点

  • 2007至2014年所有年龄组年度PSA筛查率均下降,≥70岁男性从22.8%降至8.9%。
  • 非裔美国男性总体筛查率低于非非裔美国男性,有前列腺癌家族史者筛查率相似或略高。
  • 初级保健提供者间PSA检测差异在USPSTF推荐后未见实质改变。

核心结论

  • 2007至2014年前列腺癌筛查率下降,即使在高风险群体中亦然,且随访筛查率与既往PSA水平无关。
  • 在较晚年份,接受PSA筛查的非裔美国男性和有前列腺癌家族史男性中首次前列腺活检率升高。
  • 初级保健提供者间PSA检测存在差异,未来工作应进一步探索筛查实践差异的来源及在初级保健中实施基于风险的前列腺癌筛查策略。

研究设计与样本

  • 回顾性队列研究。
  • 研究人群为160 211名年龄≥40岁、在研究年份中至少一次就诊于初级保健诊所的男性。
  • 使用2007年1月至2014年12月的电子病历数据,评估初级保健提供者年度筛查PSA检测率、重复筛查率和前列腺活检率。

主要发现

  • 年度PSA筛查率从2007年至2014年在所有年龄组均下降,≥70岁男性从22.8%降至8.9%。
  • 50-69岁男性从39.2%降至20%,40-49岁男性从11%降至4.6%。
  • 非裔美国男性总体筛查率低于非非裔美国男性,有前列腺癌家族史男性筛查率相似或略高于无家族史者。
  • 2011-2014年与2007-2010年相比,初始PSA水平<1 ng/mL或1-3 ng/mL的45-75岁男性重复筛查率相似;初始PSA<3 ng/mL的>75岁男性随访筛查率相似。
  • 2014年与2007年相比,≥70岁男性前列腺活检率下降;较晚年份中,接受PSA筛查的非裔美国男性和有前列腺癌家族史男性首次前列腺活检率升高。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为未来工作应进一步探索筛查实践差异的来源及在初级保健中实施基于风险的前列腺癌筛查策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess prostate cancer screening practices in primary care since the initial United States Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA) testing for older men, and to assess primary provider variation associated with prostate cancer screening. PATIENTS AND METHODS: Our study population included 160 211 men aged ≥40 years with at least one visit to a primary care clinic in any of the study years in a large, integrated health system. We conducted a retrospective cohort study using electronic medical record data from January 2007 to December 2014. Yearly rates of screening PSA testing by primary care providers (PCPs), rates of re-screening, and rates of prostate biopsies were assessed. RESULTS: Annual PSA-screening testing declined from 2007 to 2014 in all age groups, as did biennial and quadrennial screening. Yearly rates declined for men aged ≥70 years, from 22.8% to 8.9%; ages 50-69 years, from 39.2% to 20%; and ages 40-49 years, from 11% to 4.6%. Overall rates were lower for African-American (A-A) men vs non-A-A men; for men with a family history of prostate cancer, rates were similar or slightly higher than for those without a family history. PCP variation associated with ordering of PSA testing did not substantially change after the USPSTF recommendations. While the number of men screened and rates of follow-up prostate cancer screening declined in 2011-2014 compared to 2007-2010, similar re-screening rates were noted for men aged 45-75 years with initial PSA levels of <1 ng/mL or 1-3 ng/mL in both the earlier and later cohorts. For men aged >75 years with initial PSA levels of <3 ng/mL screened in both cohorts, follow-up screening rates were similar. Rates of prostate biopsy declined for men aged ≥70 years in 2014 compared to 2007. For men who had PSA screening, rates of first prostate biopsy increased in later years for A-A men and men with a family history of prostate cancer. CONCLUSIONS: Prostate cancer screening declined from 2007 to 2014 even in higher-risk groups and follow-up screening rates were not related to previous PSA level. However, rates of first prostate biopsy in men who were screened with a PSA test were higher for men with an increased risk of prostate cancer in later years. Variation in PSA testing was noted among PCPs. Future work should further explore sources of variation in screening practices and implementation of risk-based strategies for prostate cancer screening in primary care.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Misra-Hebert AD, Hu B, Klein EA, et al. Prostate cancer screening practices in a large, integrated health system: 2007-2014. BJU Int. 2017. PMID: 28139034. doi:10.1111/bju.13793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。